UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Expert Consensus on the Management of Adverse Events from EGFR Tyrosine Kinase Inhibitors in the UK

Drugs (New York, N.Y.), 2015-08, Vol.75 (12), p.1335-1348

2015

Volltextzugriff (PDF)

Prevalence and correlates of unmet supportive care needs in patients with resected invasive cutaneous melanoma

Annals of oncology, 2014-10, Vol.25 (10), p.2052-2058

2014

Volltextzugriff (PDF)

Systematic review of the clinical effectiveness and cost-effectiveness, and economic evaluation, of denosumab for the treatment of bone metastases from solid tumours

Health technology assessment (Winchester, England), 2013-07, Vol.17 (29), p.1-386

2013

Volltextzugriff (PDF)

59 Management of ALK rearranged non-small cell lung cancer (NSCLC) diagnosed at the Leeds Cancer Centre between 2013 and 2015

Lung cancer (Amsterdam, Netherlands), 2016, Vol.91, p.S22-S22

2016

Volltextzugriff (PDF)

91 An analysis of the current management practices of radically treatable non-small cell lung cancer at St James's University Hospital

Lung cancer (Amsterdam, Netherlands), 2014, Vol.83, p.S34-S34

2014

Volltextzugriff (PDF)

A phase Ib dose-escalation study of everolimus combined with cisplatin and etoposide as first-line therapy in patients with extensive-stage small-cell lung cancer

Annals of oncology, 2014-02, Vol.25 (2), p.505-511

2014

Volltextzugriff (PDF)

147 Lung cancer survival in different ethnic groups in Leeds: Results of a 16,000 patient population study

Lung cancer (Amsterdam, Netherlands), 2013, Vol.79, p.S49-S50

2013

Volltextzugriff (PDF)

39 Are we ageist? The impact of patient age on chemotherapy treatment decisions in advanced non-small cell lung cancer at St James's Institute of Oncology

Lung cancer (Amsterdam, Netherlands), 2013, Vol.79, p.S13-S14

2013

Volltextzugriff (PDF)

77 Analysis of the effectiveness of written clinical communication about lung cancer patients at St James's Institute of Oncology, Leeds

Lung cancer (Amsterdam, Netherlands), 2012, Vol.75, p.S26-S26

2012

Volltextzugriff (PDF)

62: A retrospective multicentre audit of outcome among patients with anaplastic lymphoma kinase (ALK) gene rearrangement positive non-small cell lung cancer (NSCLC) who have been treated with crizotinib in England

Lung cancer (Amsterdam, Netherlands), 2017, Vol.103, p.S28-S29

2017

Volltextzugriff (PDF)

28 Retrospective evaluation of 200 patients managed with second-line erlotinib at St James's Institute of Oncology, Leeds

Lung cancer (Amsterdam, Netherlands), 2013, Vol.79, p.S10-S10

2013

Volltextzugriff (PDF)

91 Follow-up of patients with advanced NSCLC following 1st line chemotherapy. A British Thoracic Oncology Group national survey

Lung cancer (Amsterdam, Netherlands), 2012, Vol.75, p.S30-S31

2012

Volltextzugriff (PDF)

Phase I investigation of recombinant anti-human vascular endothelial growth factor antibody in patients with advanced cancer

European journal of cancer (1990), 2005-03, Vol.41 (4), p.555-563

2005

Volltextzugriff (PDF)

A phase II study of combined intravenous and subcutaneous interleukin-2 in malignant pleural mesothelioma

Lung cancer (Amsterdam, Netherlands), 2001, Vol.31 (1), p.67-72

2001

Volltextzugriff (PDF)

Time taken from initial referral to start of treatment in patients with small cell lung cancer – (SCLC) An audit of practice at University Hospitals of Leicester (UHL) NHS Trust in 2002 and 2006

Lung cancer (Amsterdam, Netherlands), 2008, Vol.60, p.S14-S14

2008

Volltextzugriff (PDF)

Simian virus 40 and human pleural mesothelioma

Thorax, 1999-01, Vol.54 (1), p.60-61

1999

Volltextzugriff (PDF)

Immunocytoma: A Retrospective Analysis From St Bartholomew's Hospital—1972 to 1996

Journal of clinical oncology, 1999-09, Vol.17 (9), p.2847-2853

1999

Volltextzugriff (PDF)

P1.13-17 Multicentre Phase II Trial of First-Line Afatinib in Patients with Suspected/Confirmed EGFR Mutant NSCLC: ctDNA and Long-Term Efficacy

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S588-S589

2018

Volltextzugriff (PDF)

Qualitative Interviews To Provide In-Depth Understanding Of The Impact Of Non-Small Cell Lung Cancer (Nsclc) And Its Treatment On Of The Lives Of Patients And Their Families/Caregivers

Value in health, 2015-11, Vol.18 (7), p.A469-A469

2015

Volltextzugriff (PDF)

PCN220 - Qualitative Interviews To Provide In-Depth Understanding Of The Impact Of Non-Small Cell Lung Cancer (Nsclc) And Its Treatment On Of The Lives Of Patients And Their Families/Caregivers

Value in health, 2015-11, Vol.18 (7), p.A469-A469

2015

Volltextzugriff (PDF)

A Novel Phase Ii Trial of Ipilimumab, Carboplatin and Etoposide (Ice) for the First Line Treatment of Extensive Stage Small Cell Lung Cancer (Sclc)

Annals of oncology, 2014-09, Vol.25, p.iv516

2014

Volltextzugriff (PDF)

1477PA NOVEL PHASE II TRIAL OF IPILIMUMAB, CARBOPLATIN AND ETOPOSIDE (ICE) FOR THE FIRST LINE TREATMENT OF EXTENSIVE STAGE SMALL CELL LUNG CANCER (SCLC)

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv516-iv516

2014

Volltextzugriff (PDF)

Simian virus 40 and human pleural mesothelioma

Thorax, 1999-08, Vol.54 (8), p.750-750

JASANI, BHARAT

1999

Volltextzugriff (PDF)

Reinforcer specificity of the suppression of instrumental performance on a non-contingent schedule

Behavioural processes, 1989-06, Vol.19 (1), p.167-180

1989

Volltextzugriff (PDF)

Evidence for a schedule-dependent deleterious interaction between paclitaxel, vinblastine and cisplatin (PVC) in the treatment of advanced transitional cell carcinoma

British journal of cancer, 2000-12, Vol.83 (12), p.1612-1616

2000

Volltextzugriff (PDF)

1 – 25 von 104

Suche als RSS-Feed

Aktive Filter

KollektionOxford Journals 2020 Medicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(103)
Mit Volltextzugriff
(93)

Publikationsform

Artikel
(104)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(44)
Science & Technology
(44)
Humans
(37)
Biological And Medical Sciences
(27)
Female
(25)
Medical Sciences
(24)
Male
(23)
Hypertension
(20)
Middle Aged
(18)
Adult
(16)
Aged
(12)
Cardiovascular System & Cardiology
(12)
Peripheral Vascular Disease
(12)
Hematology, Oncology And Palliative Medicine
(9)
Pulmonary/respiratory
(9)
Endocrinology & Metabolism
(8)
Oncology
(8)
Pharmacology. Drug Treatments
(8)
Risk Factors
(8)
Arterial Hypertension. Arterial Hypotension
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Expert Consensus on the Management of Adverse Events from EGFR Tyrosine Kinase Inhibitors in the UK

Prevalence and correlates of unmet supportive care needs in patients with resected invasive cutaneous melanoma

Systematic review of the clinical effectiveness and cost-effectiveness, and economic evaluation, of denosumab for the treatment of bone metastases from solid tumours

59 Management of ALK rearranged non-small cell lung cancer (NSCLC) diagnosed at the Leeds Cancer Centre between 2013 and 2015

91 An analysis of the current management practices of radically treatable non-small cell lung cancer at St James's University Hospital

A phase Ib dose-escalation study of everolimus combined with cisplatin and etoposide as first-line therapy in patients with extensive-stage small-cell lung cancer

147 Lung cancer survival in different ethnic groups in Leeds: Results of a 16,000 patient population study

39 Are we ageist? The impact of patient age on chemotherapy treatment decisions in advanced non-small cell lung cancer at St James's Institute of Oncology

77 Analysis of the effectiveness of written clinical communication about lung cancer patients at St James's Institute of Oncology, Leeds

62: A retrospective multicentre audit of outcome among patients with anaplastic lymphoma kinase (ALK) gene rearrangement positive non-small cell lung cancer (NSCLC) who have been treated with crizotinib in England

28 Retrospective evaluation of 200 patients managed with second-line erlotinib at St James's Institute of Oncology, Leeds

91 Follow-up of patients with advanced NSCLC following 1st line chemotherapy. A British Thoracic Oncology Group national survey

Phase I investigation of recombinant anti-human vascular endothelial growth factor antibody in patients with advanced cancer

A phase II study of combined intravenous and subcutaneous interleukin-2 in malignant pleural mesothelioma

Time taken from initial referral to start of treatment in patients with small cell lung cancer – (SCLC) An audit of practice at University Hospitals of Leicester (UHL) NHS Trust in 2002 and 2006

Simian virus 40 and human pleural mesothelioma

Immunocytoma: A Retrospective Analysis From St Bartholomew's Hospital—1972 to 1996

P1.13-17 Multicentre Phase II Trial of First-Line Afatinib in Patients with Suspected/Confirmed EGFR Mutant NSCLC: ctDNA and Long-Term Efficacy

Qualitative Interviews To Provide In-Depth Understanding Of The Impact Of Non-Small Cell Lung Cancer (Nsclc) And Its Treatment On Of The Lives Of Patients And Their Families/Caregivers

PCN220 - Qualitative Interviews To Provide In-Depth Understanding Of The Impact Of Non-Small Cell Lung Cancer (Nsclc) And Its Treatment On Of The Lives Of Patients And Their Families/Caregivers

A Novel Phase Ii Trial of Ipilimumab, Carboplatin and Etoposide (Ice) for the First Line Treatment of Extensive Stage Small Cell Lung Cancer (Sclc)

1477PA NOVEL PHASE II TRIAL OF IPILIMUMAB, CARBOPLATIN AND ETOPOSIDE (ICE) FOR THE FIRST LINE TREATMENT OF EXTENSIVE STAGE SMALL CELL LUNG CANCER (SCLC)

Simian virus 40 and human pleural mesothelioma

Reinforcer specificity of the suppression of instrumental performance on a non-contingent schedule

Evidence for a schedule-dependent deleterious interaction between paclitaxel, vinblastine and cisplatin (PVC) in the treatment of advanced transitional cell carcinoma

Aktive Filter

Suchergebnisse filtern